Page 4 - Junshi Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Junshi bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Junshi Bioscience Today - Breaking & Trending Today

Junshi Biosciences Announces Acceptance of the Supplemental New Drug Application for Toripalimab

Junshi Biosciences Announces Acceptance of the Supplemental New Drug Application for Toripalimab
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , San Francisco , United States , Junshi Bioscienceszhi Li , Junshi Bioscience , Junshi Biosciences , University Cancer Hospital , Regulatory Agency , Radiographic Review Committee , Pr Team , Junshi Biosciences Contact Informationir Team , National Reimbursement Drug List , Drug Administration , Shanghai Jiao Tong University School Of Medicine , National Medical Products Administration , European Medicines Agency , Global Research , International Metastatic Renal Cell Carcinoma Database Consortium , Shanghai Junshi Biosciences Co Ltd , Chinese Medical Journal , Professor Jun , Peking University Cancer Hospital , Professor Yiran , Renji Hospital , Shanghai Jiao Tong University School , Development President ,

Junshi Biosciences Announces Initiation of Phase 3 Study of Tifcemalimab plus Toripalimab for Treatment of Limited-stage Small Cell Lung Cancer

SHANGHAI, China, June 29, 2023 (GLOBE NEWSWIRE) Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and comme. ....

San Francisco , United States , United Kingdom , Junshi Biosciences , Zhi Li , Junshi Bioscience , Drug Administration , Regulatory Agency , Ir Team , Shandong Cancer Hospital Institute , Shanghai Junshi Biosciences Co Ltd , European Medicines Agency , Pr Team , Global Research , National Reimbursement Drug List , Shandong Cancer Hospital , Development President , Southeast Asia , Biologics License Application , Breakthrough Therapy , Fast Track , Orphan Drug , Emergency Use Authorizations ,

Toripalimab Plus Chemo Elicits Significant OS Improvement in Recurrent or Metastatic Nasopharyngeal Carcinoma

First-line treatment with toripalimab in combination with gemcitabine and cisplatin resulted in a statistically significant and clinically meaningful improvement in overall survival and progression-free survival vs placebo plus chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma. ....

Junshi Bioscience , Coherus Biosciences , Junshi Biosciences , Coherus Biosciences Inc , Shanghai Junshi Biosciences Co Ltd , Maih Q , Chenq Y , Toripalimab In Combination With Gemcitabine And Cisplatin , Patients With Recurrent Or Metastatic Nasopharyngeal Carcinoma , Jupiter 02 Trial , Jennifer Choe , Vanderbilt University Medical Center ,

Sub: Transcript of the Earnings call conducted on May 10, 2023 - Form 6-K

Sub: Transcript of the Earnings call conducted on May 10, 2023

Pursuant to Regulation 30 of Securities and Exchange Board of India Regulations, 2015, please find enclosed the. | May 16, 2023 ....

New Zealand , United States , United Kingdom , Damayanti Kerai , Parag Agawwal , Ashish Thavkar , Ankush Mahajan , Surya Patra , Kunal Dhamesha , Cyndrella Carvalho , Tushar Manudhane , K Randhir Singh , Richa Periwal , Prakash Agarwal , Mayne Pharma , Nitin Agarwal , Neha Manpuria , Madhav Marda , Erez Isreali , Ashishs Thavkar , Parag Agarwal , Cyndrella Thomas Carvalho , Junshi Bioscience , Balaji Prasad , Reddy Laboratories , Motilal Oswal Financial Services ,

Junshi Biosciences Announces Collaboration with Dr. Reddy's to Develop and Commercialize Toripalimab in 21 Countries

SHANGHAI, China, May 07, 2023 Shanghai Junshi Biosciences Co., Ltd announced a collaboration with Dr. Reddy’s Laboratories Limited to develop and commercialize toripalimab, the anti-PD-1. | May 7, 2023 ....

United Kingdom , New Zealand , South Africa , Andhra Pradesh , United States , San Francisco , Zhi Li , Junshi Biosciences , Junshi Bioscience , National Stock Exchange Of India , York Stock Exchange , Good Health Cant Wait , Ir Team , National Reimbursement Drug List , Bombay Stock Exchange , Pr Team , New York Stock Exchange , Regulatory Agency , Shanghai Junshi Biosciences Co Ltd , Drug Administration , European Medicines Agency , Reddy Laboratories Limited Dr , Laboratories Limited , Latin America , For Global , Chief Executive Officer ,